实施丙型肝炎病毒直接抗病毒药物去中心化治疗的有效性:系统评价与荟萃分析
一项系统评价与荟萃分析,评估非专科人员实施直接抗病毒药物去中心化治疗丙型肝炎的有效性,主要终点为SVR12。

基本信息
资源简介
实施丙型肝炎病毒直接抗病毒药物去中心化治疗的有效性:系统评价与荟萃分析
【一句话概览】
本数据集是 figshare 公开的文本数据集,收录 13 个文件、合计 13.70 MB,主题涵盖 virologic response rate、RR、PROSPERO、hepatitis C virus treatment、CRD,可用于医学自然语言处理(实体识别、信息抽取等),CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Effectiveness of implementing a decentralized delivery of hepatitis C virus treatment with direct-acting antivirals: A systematic review with meta-analysis》。配套论文《Effectiveness of implementing a decentralized delivery of hepatitis C virus treatment with direct-acting antivirals: A systematic review with meta-analysis》发表于 PLOS ONE(2020),DOI:10.1371/journal.pone.0229143。源站首次发布:2020-02-21。
【数据内容】
源站原始描述:Direct-acting agents (DAAs) for hepatitis C virus (HCV) treatment are safe and highly effective. Few studies described the sustained virologic response rates of treatment conducted by non-specialists. We performed a systematic review and meta‐analysis to evaluate the effectiveness of decentralized strategies of HCV treatment with DAAs. PubMed, Embase, Scopus and LILACS were searched until March-2019. Studies were screened by two researchers according to the following inclusion criteria: HCV trea…
【数据结构与技术规格】
文件数 13 个,合计 13.70 MB。pone.0229143.s001.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,19.43 KB。pone.0229143.s002.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,16.78 KB。pone.0229143.s003.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,18.80 KB。数据集 DOI:10.1371/journal.pone.0229143。
【主题与分类】
源站学科分类:Medicine、Cell Biology、Biotechnology、Chemical Sciences not elsewhere classified、Biological Sciences not elsewhere classified、Science Policy。主题标签:virologic response rate、RR、PROSPERO、hepatitis C virus treatment、CRD、NIH Quality Assessment Tool、virologic response rates、hepatitis C virus、strategy、March -2019. Studies。
【适用方向】
文本类数据可用于医学自然语言处理,如命名实体识别、信息抽取与文本分类。
【获取与许可】
源站页面:https://plos.figshare.com/articles/dataset/Effectiveness_of_implementing_a_decentralized_delivery_of_hepatitis_C_virus_treatment_with_direct-acting_antivirals_A_systematic_review_with_meta-analysis/11883693
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Castro, Rodolfo; Perazzo, Hugo; de Araujo, Letícia Artilles Mello Mendonça; Gutierres, Isabella Gonçalves; Grinsztejn, Beatriz; Veloso, Valdiléa G. (2020). Effectiveness of implementing a decentralized delivery of hepatitis C virus treatment with direct-acting antivirals: A systematic review with me…
【使用注意】
· 源站最后修改于 2023-06-01,引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:Effectiveness of implementing a decentralized delivery of hepatitis C virus treatment with direct-acting antivirals: A systematic review with meta-analysis
- DOI:10.1371/journal.pone.0229143
- 发布日期:2020-02-21
- 文件数:13 个
- 文件总体积:13.70 MB
- 源站页面:https://plos.figshare.com/articles/dataset/Effectiveness_of_implementing_a_decentralized_delivery_of_hepatitis_C_virus_treatment_with_direct-acting_antivirals_A_systematic_review_with_meta-analysis/11883693
命令行下载
curl -L -o "pone.0229143.s001.docx" "https://ndownloader.figshare.com/files/21789309"
curl -L -o "pone.0229143.s002.docx" "https://ndownloader.figshare.com/files/21789312"
curl -L -o "pone.0229143.s003.docx" "https://ndownloader.figshare.com/files/21789315"
curl -L -o "pone.0229143.s004.tif" "https://ndownloader.figshare.com/files/21789321"
curl -L -o "pone.0229143.s005.tif" "https://ndownloader.figshare.com/files/21789324"
curl -L -o "pone.0229143.s006.tif" "https://ndownloader.figshare.com/files/21789327"
curl -L -o "pone.0229143.s007.tif" "https://ndownloader.figshare.com/files/21789333"
curl -L -o "pone.0229143.s008.tif" "https://ndownloader.figshare.com/files/21789336"
文件清单
pone.0229143.s001.docx(19.43 KB)pone.0229143.s002.docx(16.78 KB)pone.0229143.s003.docx(18.80 KB)pone.0229143.s004.tif(3.22 MB)pone.0229143.s005.tif(3.22 MB)pone.0229143.s006.tif(132.10 KB)pone.0229143.s007.tif(128.41 KB)pone.0229143.s008.tif(142.45 KB)pone.0229143.s009.tif(143.11 KB)pone.0229143.s010.tif(136.02 KB)pone.0229143.s011.tif(3.22 MB)pone.0229143.s012.tif(3.22 MB)pone.0229143.s013.doc(65.02 KB)
文件总体积 13.70 MB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
Direct-acting agents (DAAs) for hepatitis C virus (HCV) treatment are safe and highly effective. Few studies described the sustained virologic response rates of treatment conducted by non-specialists. We performed a systematic review and meta‐analysis to evaluate the effectiveness of decentralized strategies of HCV treatment with DAAs. PubMed, Embase, Scopus and LILACS were searched until March-2019. Studies were screened by two researchers according to the following inclusion criteria: HCV treatment using DAAs on real-life cohort studies or clinical trials conducted by non-specialized health personnel. The primary endpoint was the sustained virologic response rate at week 12 after the end-of-treatment (SVR12), which is binary at the patient level. Data were extracted in duplicate using electronic-forms and quality appraisal was performed with the NIH Quality Assessment Tool. Heterogeneity was assessed by I2 statistics. Random-effects meta-analysis models were used for pooling SVR12 rates. Publication bias was assessed using funnel plots. Among the 130 selected studies, nine papers were included for quantitative synthesis. The quality-appraisal was good for two, fair for three and poor for four studies. The pooled relative risk (RR) of SVR12 was not statistically different between decentralized strategy and treatment by specialists [RR = 1.05; 95% confidence interval (95% CI): 0.98–1.1; I2 = 45% (95% CI: 0–84%), p = 0.145]. SVR12 rate for decentralized HCV treatment was 81% [SVR12 95% CI: 72–89%; I2 = 93% (95% CI: 88–96%)] and 95% [SVR12 95%CI: 92–98%; I2 = 77% (95% CI: 52–89%)] with intention to treat analysis and per-protocol analysis, respectively. SVR12 rates using DAAs managed by non-specialized health personnel were satisfactory and similar to those obtained by specialists. This new delivery strategy can improve access to HCV treatment, especially in resource-limited settings. PROSPERO #: CRD42019122609.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.1371/journal.pone.0229143(source: https://plos.figshare.com/articles/dataset/Effectiveness_of_implementing_a_decentralized_delivery_of_hepatitis_C_virus_treatment_with_direct-acting_antivirals_A_systematic_review_with_meta-analysis/11883693)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




